FDA Investigator Kimberly A Dux
Kimberly A Dux has conducted inspections on 411 sites in 4 countries as of 06 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
411
Last Inspection Date:
06 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Brazil,
Dominican Republic
FDA Investigators that have inspected at least one site in common with Kimberly A Dux:
Alan D Centi,
Albert A Salvador,
Alexander M Kay,
Amanda B Athey,
Amanda B Vega,
Amy A Johnson,
Anastasia I Onuorah,
Anastasia M Shields,
Andrea D Swingle,
Anita R Michael,
Ann Marie Karnick,
Anne E Johnson,
Barbara A Gullick,
Brandon J Brookens,
Brandon L Mariner,
Brian S Keefer,
Cara M Minelli,
Carl E Lovrich,
Carmen Y Fisher,
CDR Kimberly Y Martin,
CDR Michael J Mero,
Celeta S Coves,
Chamberlain,
Colleen M Damon,
Corrine M Carter,
Courtney N Long,
Craig D Zagata,
Cynthia F Kleppinger, MD,
Cynthia L Rakestraw,
Daniel J Mechenbier,
Daniel L Aisen,
Daniel W Johnson,
David L Duncan,
David L Pearce,
Dawn C Olenjack,
Dawn D Aiello,
Donald W Myrick,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Edward D Mcdonald,
Edwin L Hobbs,
Emily A Walters,
Eric T Huebler,
Erica L Nicoll,
Erika M Wilkerson,
Ethan P Stegman,
Eufemia G Gonzalez,
Gabrielle J Swain,
Gajendiran Mahadevan, PhD,
Gayle S Lawson,
Gene R Gunn,
Gina C Collins,
Gloria J Baca, MS,
Hasan A Irier, PhD,
Jacob M Dyer,
James P Mcevoy,
Jason M Sluzynski,
Jennifer C Adams,
Jessica E Hensley,
John A Iwen,
Joseph L Despins, PhD,
Joshua C Schafer,
Juanita P Versace,
Judith A Paterson,
Judy Ellen Ciaraldi,
Julianne C Mccullough,
Kara A Scheibner, PhD,
Kathryn A Krentz,
Kelly N Kerr,
Kenneth L Smalls,
Kip J Hanks,
Kish Bolden,
LCDR Ismael Olvera, IV,
LCDR Margaret Edi Gennaro,
Li Hongpaul Yeh, PhD,
Linda M Hoover,
Linda S Mattingly,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Mark W Babbitt,
Marlene L Davis,
Matthew R Noonan,
Maureen A Wentzel,
Megan F Mclaughlin,
Megan M Lauff,
Melissa M Dauksis,
Michele Gottshall,
Michele M Falchek,
Mike M Rashti,
Myra K Casey,
Myrick,
Nancy L Rose,
Neal D Singletary, PhD,
Nicola M Fenty Stewart,
Nikisha M Bolden,
Patricia H Dlugosz,
Peter Kessler, PhD,
Rebecca T Davis,
Richard J Bashay,
Rita F Larocca Mahoney,
Robert B Shibuya, MD,
Ruark Lanham,
Ruben C Ayala, PharmD,
Sarah Forney,
Sean D Duke,
Shelley L Waring,
Shusheen A Alexander,
Sripal R Mada, PhD,
Stephanie Mangigian, MS/OSH, RN,
Sunitha K Rajaram, PhD,
Tammy L Chavis,
Timothy J Schmidt,
Todd J Maushart,
Travis R Hunt,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vickie J Kanion,
Vlada Matusovsky,
William C Brenneman,
William F Lagud, Jr,
Young M Choi, PhD,
Yvonne T Lacour
Kimberly A Dux's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2003 | EIR | Sky Medical, Llc - EIR, 2003-08-11 |
July, 2013 | FDA 483 | Dr. Monica Hermida Cerqueira - Form 483, 2013-07-19 |
November, 2003 | FDA 483 Response | Grifols Biomat - Form 483R, 2004-01-12 |
July, 2008 | FDA 483 | American National Red Cross, Penn Jersey Region - Form 483, 2008-07-29 |
February, 2015 | EIR | Raptim Research Private Limited - EIR, 2015-02-09 |
December, 2014 | EIR | Penn State Milton S Hershey Medical Center - EIR, 2014-12-12 |
June, 2010 | FDA 483 | American National Red Cross, Penn Jersey Region - Form 483, 2010-06-04 |
February, 2015 | EIR | Raptim Research Private Limited - EIR, 2015-02-20 |
April, 2003 | EIR | Geisinger Institutional Review Board - EIR, 2003-04-09 |
November, 2003 | EIR | Grifols Biomat - EIR, 2003-11-13 |
November, 2003 | FDA 483 | Grifols Biomat - Form 483, 2003-11-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more